
NeuroMetrix NURO
Annual report 2024
added 03-31-2025
Country |
|
IPO year |
2004 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
1.97 M |
Market Cap[1] |
$ 9.02 M |
EBITDA (LTM) |
$ -7.81 M |
P/E (LTM) |
- |
P/S (LTM) |
2.47 |
EPS (LTM) |
-4.82 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Ekso Bionics Holdings
EKSO
|
$ 10.0 | -2.25 % | $ 24.3 M | Nasdaq Capital Market | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
AtriCure
ATRC
|
$ 31.46 | 1.71 % | $ 1.5 B | Nasdaq Global Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
The Cooper Companies
COO
|
$ 83.37 | -0.66 % | $ 16.6 B | NYSE,SPB | ||
|
Alcon
ALC
|
$ 83.08 | -1.89 % | $ 40.4 B | NYSE | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Baxter International
BAX
|
$ 19.03 | -3.35 % | $ 9.76 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Glaukos Corporation
GKOS
|
$ 117.75 | -2.78 % | $ 5.7 B | NYSE,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 65.63 | 2.74 % | $ 3.3 B | NYSE,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Harvard Bioscience
HBIO
|
$ 0.57 | -4.31 % | $ 24.2 M | Nasdaq Global Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 174.21 | -1.32 % | $ 50.1 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 11.04 | -2.82 % | $ 451 M | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 125.85 | -2.03 % | $ 4.03 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.77 | -2.05 % | $ 218 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 107.85 | 0.42 % | $ 2.44 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 175.36 | -0.02 % | $ 9.35 B | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.39 | -3.63 % | $ 24.4 M | Nasdaq Global Select Market | ||
|
BioLife Solutions
BLFS
|
$ 20.17 | -10.44 % | $ 929 M | Nasdaq Global Select Market | ||
|
Nephros
NEPH
|
$ 3.87 | -5.15 % | $ 40.2 M | Nasdaq Global Select Market | ||
|
electroCore
ECOR
|
$ 7.61 | -2.06 % | $ 42 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 28.67 | -2.62 % | $ 4.82 B | NYSE | ||
|
ResMed
RMD
|
$ 258.28 | 0.35 % | $ 37.7 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.69 | 4.48 % | $ 20.7 M | NYSE American | ||
|
Pulse Biosciences
PLSE
|
$ 17.95 | -4.77 % | $ 1.21 B | Nasdaq Global Select Market | ||
|
ICU Medical
ICUI
|
$ 142.66 | -2.95 % | $ 3.52 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.18 | -1.4 % | $ 190 M | NYSE American | ||
|
Intuitive Surgical
ISRG
|
$ 497.42 | 0.24 % | $ 178 B | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 123.06 | -1.53 % | $ 6.86 M | Nasdaq Global Select Market,SPB | ||
|
STERIS plc
STE
|
$ 243.35 | -1.78 % | $ 24 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 122.19 | -0.6 % | $ 5.45 B | NYSE,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 74.85 | -2.16 % | $ 4.43 B | Nasdaq Global Select Market,SPB | ||
|
Utah Medical Products
UTMD
|
$ 66.51 | -0.86 % | $ 241 M | Nasdaq Global Select Market | ||
|
STAAR Surgical Company
STAA
|
$ 18.92 | -0.68 % | $ 938 M | Nasdaq Global Market,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 251.38 | 0.05 % | $ 18.2 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 13.3 | -7.06 % | $ 2.65 B | Nasdaq Global Select Market,SPB | ||
|
OraSure Technologies
OSUR
|
$ 2.98 | 0.68 % | $ 222 M | Nasdaq Global Select Market,SPB | ||
|
Pro-Dex
PDEX
|
$ 47.51 | 2.99 % | $ 156 M | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 2.14 | -3.6 % | $ 173 M | NYSE American | ||
|
Milestone Scientific
MLSS
|
$ 0.28 | 11.26 % | $ 22.3 M | NYSE American |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.